Condensed Consolidated Statements of Stockholders' Equity - USD ($)		Total	Common Stock		Additional Paid-in Capital		Accumulated Deficit	Accumulated other comprehensive loss
Beginning balance (in shares) at Dec. 31, 2019	[1]		10,214,600
Beginning balance at Dec. 31, 2019		$ 481,502,937	$ 102,146	[1]	$ 918,475,145	[1]	$ (437,074,354)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income/(loss)		(3,527,759)					(3,527,759)
Issuance of shares due to vesting of restricted shares (in shares)	[1]		62,526
Issuance of shares due to vesting of restricted shares	[1]		$ 626		(626)
Unrealized gain on cash flow hedges		(271,868)						(271,868)
Cash used to settle net share equity awards		(1,161,301)			(1,161,301)	[1]
Stock-based compensation		836,200			836,200	[1]
Ending balance (in shares) at Mar. 31, 2020	[1]		10,277,126
Ending balance at Mar. 31, 2020		477,378,209	$ 102,772	[1]	918,149,418	[1]	(440,602,113)	(271,868)
Beginning balance (in shares) at Dec. 31, 2019	[1]		10,214,600
Beginning balance at Dec. 31, 2019		481,502,937	$ 102,146	[1]	918,475,145	[1]	(437,074,354)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income/(loss)		(24,019,086)
Unrealized gain on cash flow hedges		(921,155)
Ending balance (in shares) at Jun. 30, 2020	[1]		10,279,698
Ending balance at Jun. 30, 2020		456,960,818	$ 102,798	[1]	918,872,615	[1]	(461,093,440)	(921,155)
Beginning balance (in shares) at Mar. 31, 2020	[1]		10,277,126
Beginning balance at Mar. 31, 2020		477,378,209	$ 102,772	[1]	918,149,418	[1]	(440,602,113)	(271,868)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income/(loss)		(20,491,327)					(20,491,327)
Issuance of shares due to vesting of restricted shares (in shares)	[1]		2,572
Issuance of shares due to vesting of restricted shares	[1]		$ 26		(26)
Unrealized gain on cash flow hedges		(649,287)						(649,287)
Stock-based compensation		723,223			723,223	[1]
Ending balance (in shares) at Jun. 30, 2020	[1]		10,279,698
Ending balance at Jun. 30, 2020		456,960,818	$ 102,798	[1]	918,872,615	[1]	(461,093,440)	(921,155)
Beginning balance (in shares) at Dec. 31, 2020			11,661,797
Beginning balance at Dec. 31, 2020		470,418,083	$ 116,618		943,571,685		(472,137,822)	(1,132,398)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income/(loss)		9,849,310					9,849,310
Issuance of shares due to vesting of restricted shares (in shares)			71,146
Issuance of shares due to vesting of restricted shares			$ 711		(711)
Unrealized gain on cash flow hedges		599,884						599,884
Fees for equity offerings		(31,830)			(31,830)
Cash used to settle net share equity awards		(811,456)			(811,456)
Stock-based compensation		871,943			871,943
Ending balance (in shares) at Mar. 31, 2021			11,732,943
Ending balance at Mar. 31, 2021		480,895,934	$ 117,329		943,599,631		(462,288,512)	(532,514)
Beginning balance (in shares) at Dec. 31, 2020			11,661,797
Beginning balance at Dec. 31, 2020		470,418,083	$ 116,618		943,571,685		(472,137,822)	(1,132,398)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income/(loss)		19,074,335
Unrealized gain on cash flow hedges								644,204
Ending balance (in shares) at Jun. 30, 2021			12,753,255
Ending balance at Jun. 30, 2021		526,258,356	$ 127,533		979,682,504		(453,063,487)	(488,194)
Beginning balance (in shares) at Mar. 31, 2021			11,732,943
Beginning balance at Mar. 31, 2021		480,895,934	$ 117,329		943,599,631		(462,288,512)	(532,514)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income/(loss)		$ 9,225,025					9,225,025
Issuance of shares due to vesting of restricted shares (in shares)			2,773
Issuance of shares due to vesting of restricted shares			$ 27		(27)
Issuance of shares upon conversion of warrants (in shares)		432,037	432,037	[2]
Issuance of shares upon conversion of warrants	[2]	$ 8,375,298	$ 4,322		8,370,976
Issuance of shares from ATM Offering, net of commissions and issuance costs (in shares)	[3]		581,385
Issuance of shares from ATM Offering, net of commissions and issuance costs	[3]	$ 27,283,917	$ 5,814		27,278,103
Issuance of shares upon exercise of stock options (in shares)		4,117
Issuance of shares upon exercise of stock options		$ 22,224	$ 41		22,183
Unrealized gain on cash flow hedges		44,320						44,320
Cash used to settle net share equity awards		(174,230)			(174,230)
Stock-based compensation		585,868			585,868
Ending balance (in shares) at Jun. 30, 2021			12,753,255
Ending balance at Jun. 30, 2021		$ 526,258,356	$ 127,533		$ 979,682,504		$ (453,063,487)	$ (488,194)

[1] Adjusted to give effect for the 1-for-7 Reverse Stock Split that became effective as of September 15, 2020, see Note 1.

[2] Please see Note 3 Vessels for additional information.

[3] Please see Note 1 Basis of presentation and general information for additional information.